| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-11 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.45 | 4e-11 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.3 | 8e-09 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 9e-05 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |